Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1982 Dec;196(6):633–635. doi: 10.1097/00000658-198212001-00002

The use of a selective beta-adrenergic receptor blocker for the preoperative preparation of thyrotoxic patients.

P Dial, P R Hastings
PMCID: PMC1352975  PMID: 7149813

Abstract

Metoprolol, a cardioselective beta-blocker, was used in two asthmatic, thyrotoxic patients in preparation for thyroidectomy. Adequate reduction in resting heart rate was achieved in both individuals without inducing clinically significant airway obstruction. Beta-1-blockade can be selectively employed in this clinical setting, but patients should be hospitalized and closely monitored for adverse effects on pulmonary function. Metoprolol therapy in patients with reversible airway obstruction is discussed with reference to recent studies on relative cardioselectivity.

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham T. A., Hasan F. M., Fenster P. E., Marcus F. I. Effect of intravenous metoprolol on reversible obstructive airways disease. Clin Pharmacol Ther. 1981 May;29(5):582–587. doi: 10.1038/clpt.1981.81. [DOI] [PubMed] [Google Scholar]
  2. Bengtsson C. The effect of metoprolol --a new selective adrenergic beta1-receptor blocking agent-- in mild hypertension. Acta Med Scand. 1976;199(1-2):65–70. doi: 10.1111/j.0954-6820.1976.tb06692.x. [DOI] [PubMed] [Google Scholar]
  3. Benson M. K., Berrill W. T., Sterling G. M., Decalmer P. B., Chatterjee S. S., Croxson R. S., Cruickshank J. M. Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease. Postgrad Med J. 1977;53 (Suppl 3):143–148. [PubMed] [Google Scholar]
  4. Bewsher P. D., Pegg C. A., Stewart D. J., Lister D. A., Michie W. Propranolol in the surgical management of thyrotoxicosis. Ann Surg. 1974 Nov;180(5):787–790. doi: 10.1097/00000658-197411000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bush R. K., Ehrlich E. N., Reed C. E. Thyroid disease and asthma. J Allergy Clin Immunol. 1977 May;59(5):398–401. doi: 10.1016/0091-6749(77)90025-2. [DOI] [PubMed] [Google Scholar]
  6. CANARY J. J., SCHAAF M., DUFFY B. J., Jr, KYLE L. H. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med. 1957 Sep 5;257(10):435–442. doi: 10.1056/NEJM195709052571001. [DOI] [PubMed] [Google Scholar]
  7. Carlson C., Järvinen K. A. Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma. Allergy. 1978 Jun;33(3):147–151. doi: 10.1111/j.1398-9995.1978.tb01525.x. [DOI] [PubMed] [Google Scholar]
  8. Comerford M. B., Besterman E. M. An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris. Postgrad Med J. 1976 Aug;52(610):481–486. doi: 10.1136/pgmj.52.610.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dillon P. T., Babe J., Meloni C. R., Canary J. J. Reserpine in thyrotoxic crisis. N Engl J Med. 1970 Nov 5;283(19):1020–1023. doi: 10.1056/NEJM197011052831904. [DOI] [PubMed] [Google Scholar]
  10. Dobyns B. M. Prevention and management of hyperthyroid storm. World J Surg. 1978 May;2(3):293–306. doi: 10.1007/BF01561498. [DOI] [PubMed] [Google Scholar]
  11. GAFFNEY T. E., BRAUNWALD E., KAHLER R. L. Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man. N Engl J Med. 1961 Jul 6;265:16–20. doi: 10.1056/NEJM196107062650104. [DOI] [PubMed] [Google Scholar]
  12. Koch-Weser J. Drug therapy: metoprolol. N Engl J Med. 1979 Sep 27;301(13):698–703. doi: 10.1056/NEJM197909273011306. [DOI] [PubMed] [Google Scholar]
  13. Lee T. C., Coffey R. J., Mackin J., Cobb M., Routon J., Canary J. J. The use of propranolol in the surgical treatment of thyrotoxic patients. Ann Surg. 1973 Jun;177(6):643–647. [PMC free article] [PubMed] [Google Scholar]
  14. McDevitt D. G., Nelson J. K. Comparative trial of atenolol and propranolol in hyperthyroidism. Br J Clin Pharmacol. 1978 Sep;6(3):233–237. doi: 10.1111/j.1365-2125.1978.tb04590.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murchison L. E., How J., Bewsher P. D. Comparison of propranolol and metoprolol in the management of hyperthyroidism. Br J Clin Pharmacol. 1979 Dec;8(6):581–587. doi: 10.1111/j.1365-2125.1979.tb01048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nilsson O. R., Melander A., Tegler L. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients. Eur J Clin Pharmacol. 1980 Oct;18(4):315–320. doi: 10.1007/BF00561388. [DOI] [PubMed] [Google Scholar]
  17. Raine J. M., Palazzo M. G., Kerr J. H., Sleight P. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br Med J (Clin Res Ed) 1981 Feb 14;282(6263):548–549. doi: 10.1136/bmj.282.6263.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Settipane G. A., Schoenfeld E., Hamolsky M. W. Asthma and hyperthyroidism. J Allergy Clin Immunol. 1972 Jun;49(6):348–355. doi: 10.1016/0091-6749(72)90133-9. [DOI] [PubMed] [Google Scholar]
  19. Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]
  20. Skinner C., Gaddie J., Palmer K. N. Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction. Br Med J. 1976 Feb 28;1(6008):504–504. doi: 10.1136/bmj.1.6008.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest. 1977 Apr;71(2):73–86. doi: 10.1016/0007-0971(77)90086-9. [DOI] [PubMed] [Google Scholar]
  22. Turner P., Granville-Grossman K. L. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet. 1965 Dec 25;2(7426):1316–1318. doi: 10.1016/s0140-6736(65)92340-8. [DOI] [PubMed] [Google Scholar]
  23. Turner P. Relative importance of cardioselectivity and partial agonism in the treatment of hypertension in the patient with air-flow obstruction. Cardiology. 1979;64 (Suppl 1):105–108. doi: 10.1159/000170656. [DOI] [PubMed] [Google Scholar]
  24. Wasir H. S., Mahapatra R. K., Bhatia M. L., Roy S. B., Sannerstedt R. Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias. Br Heart J. 1977 Aug;39(8):834–838. doi: 10.1136/hrt.39.8.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zonszein J., Santangelo R. P., Mackin J. F., Lee T. C., Coffey R. J., Canary J. J. Propranolol therapy in thyrotoxicosis. A review of 84 patients undergoing surgery. Am J Med. 1979 Mar;66(3):411–416. doi: 10.1016/0002-9343(79)91060-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES